ChiisanosideCAS# 89354-01-8 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 89354-01-8 | SDF | Download SDF |
| PubChem ID | 21626427 | Appearance | White powder |
| Formula | C48H74O19 | M.Wt | 955.10 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(C4C6CC7C8C(C6(CC5)C)(CCC(C8(C(CC(=O)O7)O)C)C(=C)C)C)C(=C)C)O)O)O)CO)O)O)O | ||
| Standard InChIKey | JVLBOZIUMGNKQW-JBPVHNHLSA-N | ||
| Standard InChI | InChI=1S/C48H74O19/c1-19(2)22-9-12-48(14-13-45(6)24(30(22)48)15-25-40-46(45,7)11-10-23(20(3)4)47(40,8)28(50)16-29(51)63-25)44(60)67-43-37(58)34(55)32(53)27(65-43)18-61-41-38(59)35(56)39(26(17-49)64-41)66-42-36(57)33(54)31(52)21(5)62-42/h21-28,30-43,49-50,52-59H,1,3,9-18H2,2,4-8H3/t21-,22-,23-,24+,25+,26+,27+,28+,30+,31-,32+,33+,34-,35+,36+,37+,38+,39+,40-,41+,42-,43-,45+,46+,47+,48-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Chiisanoside has anti-rotaviral activity. 2. Chiisanoside inhibits NO and PGE2 production. 3. Chiisanoside has the potential to prevent obesity as a lipase inhibitor which suppresses fat absorption in vivo. 4. Chiisanoside has anti-oxidant activity, can inhibit xanthine oxidase activity and increase superoxide dismutase (SOD), glutathione peroxidase and catalase . 5. Chiisanoside has anti-inflammatory property, might be the result from the inhibition of iNOS, COX-2, TNF-alpha and IL-1beta expression through the down-regulation of NF-kappaB binding activity. |
| Targets | NO | PGE | TNF-α | NOS | COX | NF-kB | IL Receptor | p65 | ERK | JNK | ATPase | Potassium Channel | SOD | ROS |
Chiisanoside Dilution Calculator
Chiisanoside Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.047 mL | 5.2351 mL | 10.4701 mL | 20.9402 mL | 26.1753 mL |
| 5 mM | 0.2094 mL | 1.047 mL | 2.094 mL | 4.188 mL | 5.2351 mL |
| 10 mM | 0.1047 mL | 0.5235 mL | 1.047 mL | 2.094 mL | 2.6175 mL |
| 50 mM | 0.0209 mL | 0.1047 mL | 0.2094 mL | 0.4188 mL | 0.5235 mL |
| 100 mM | 0.0105 mL | 0.0524 mL | 0.1047 mL | 0.2094 mL | 0.2618 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- ICI 174,864
Catalog No.:BCC5675
CAS No.:89352-67-0
- 3,4-O,O-Methylene-(+)-catechin
Catalog No.:BCN7962
CAS No.:89329-14-6
- 2,4-Dihydroxy-3-nitropyridine
Catalog No.:BCC8499
CAS No.:89282-12-2
- MF63
Catalog No.:BCC1744
CAS No.:892549-43-8
- 2-(Chloromethyl)-4-(4-nitrophenyl)-1,3-thiazole
Catalog No.:BCC8372
CAS No.:89250-26-0
- AZD 3988
Catalog No.:BCC5621
CAS No.:892489-52-0
- Manidipine 2HCl
Catalog No.:BCC4405
CAS No.:89226-75-5
- Manidipine
Catalog No.:BCC4404
CAS No.:89226-50-6
- LY2334737
Catalog No.:BCC4060
CAS No.:892128-60-8
- Mulberrofuran H
Catalog No.:BCN3371
CAS No.:89199-99-5
- Fraxiresinol 1-O-glucoside
Catalog No.:BCN4439
CAS No.:89199-94-0
- Efaroxan hydrochloride
Catalog No.:BCC6797
CAS No.:89197-00-2
- Riligustilide
Catalog No.:BCC9136
CAS No.:89354-45-0
- PF 945863
Catalog No.:BCC6172
CAS No.:893556-85-9
- Imidapril HCl
Catalog No.:BCC3792
CAS No.:89396-94-1
- VU 0240551
Catalog No.:BCC5424
CAS No.:893990-34-6
- LDN 212320
Catalog No.:BCC6361
CAS No.:894002-50-7
- Raddeanin A
Catalog No.:BCN1084
CAS No.:89412-79-3
- STF-118804
Catalog No.:BCC4850
CAS No.:894187-61-2
- [D-Trp7,9,10]-Substance P
Catalog No.:BCC7202
CAS No.:89430-38-6
- DMOG
Catalog No.:BCC2433
CAS No.:89464-63-1
- BIBF 1202
Catalog No.:BCC5298
CAS No.:894783-71-2
- ST 2825
Catalog No.:BCC1967
CAS No.:894787-30-5
- TCS JNK 6o
Catalog No.:BCC7607
CAS No.:894804-07-0
Antiinflammatory effects of chiisanoside and chiisanogenin obtained from the leaves of Acanthopanax chiisanensis in the carrageenan- and Freund's complete adjuvant-induced rats.[Pubmed:15707776]
J Ethnopharmacol. 2005 Feb 28;97(2):359-67.
To find the antiinflammtory constituents of Acanthopanax chiisanensis (Araliaceae) leaves, phytochemical isolation procedures were performed by activity-guided fractionation in carrageenan- and Freund's complete adjuvant (FCA) reagent-induced rat models, respectively. In the two assay system, the MeOH extract (100 and 250 mg/kg, p.o.) showed significant antiinflammtory effects. Since BuOH extract among the fractionated extracts exhibited the most potent effect, it was subjected to column chromatography to yield a main triterpene glycoside, Chiisanoside (1). This compound was hydrolyzed in alkaline solution to find the biological activity of produced aglycone, chiisanogenin (1a). Oral treatment with compounds 1 and 1a produced significant antiinflammtory effects at 10 and 30 mg/kg dose, and 1a was more potent than 1. The antiiflammtory effects of the two compounds were supported by the reduction of carrageenan-induced lipid peroxidation and hydroxy radical in serum. Furthermore, treatment with 1 and 1a significantly reduced rheumatoid arthritis (RA) and C-reactive protein (CRP) factors in the rat induced by Freund's complete adjuvant reagent. Compounds, 1 and 1a, inhibited xanthine oxidase activity and increased superoxide dismutase (SOD), glutathione peroxidase and catalase indicating that both compounds scavenged reactive oxygen species (ROS).
Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide and cyclooxygenase-2 by chiisanoside via suppression of nuclear factor-kappaB activation in RAW 264.7 macrophage cells.[Pubmed:16204946]
Biol Pharm Bull. 2005 Oct;28(10):1919-24.
In the present study, the effects of several triterpenes isolated from the leaves of Acanthopanax chiisanensis (Araliaceae), namely, Chiisanoside, isoChiisanoside, 22-hydroxyChiisanoside and chiisanogenin (the aglycone of Chiisanoside) were evaluated on lipopolysaccharide (LPS)-induced nitric oxide (NO) and prostaglandin E2 (PGE2) production by the RAW 264.7 macrophage cell line. Of the triterpenes tested, Chiisanoside was found to most potently inhibit NO and PGE2 production. In addition, Chiisanoside significantly reduced the release of inflammatory cytokines like TNF-alpha and IL-1beta. Consistent with these observations, the protein and mRNA expression levels of iNOS and COX-2 enzyme were found to be inhibited by Chiisanoside in a concentration-dependent manner. Furthermore, Chiisanoside inhibited the nuclear factor-kappaB (NF-kappaB) activation induced by LPS and this was associated with a reduction in p65 protein in the nucleus and with the phosphorylations of ERK1/2 and JNK MAP kinases. Taken together, our data indicate that the anti-inflammatory properties of Chiisanoside might be the result from the inhibition of iNOS, COX-2, TNF-alpha and IL-1beta expression through the down-regulation of NF-kappaB binding activity.
Metabolism of chiisanoside from Acanthopanax divaricatus var. albeofructus by human intestinal bacteria and its relation to some biological activities.[Pubmed:11379786]
Biol Pharm Bull. 2001 May;24(5):582-5.
The metabolic pathway of Chiisanoside isolated from leaves of Acanthopanax divaricatus var. albeofructus (Araliaceae) by human intestinal bacteria and by the protein fraction of leaves of this plant were investigated, and the cytotoxic and anti-rotaviral activities of Chiisanoside and its metabolite, chiisanogenin, were assayed. Chiisanogenin was produced as a main metabolite, when Chiisanoside were incubated for 15 h with human intestinal bacteria. This metabolic pathway proceeded more potently with the protein fraction than with human intestinal bacteria. The in vitro cytotoxicity of chiisanogenin was superior to that of Chiisanoside. H+/K+ ATPase was more potently inhibited by chiisanogenin than by Chiisanoside. However, the anti-rotaviral activity of Chiisanoside was more potent than that of chiisanogenin.
Chiisanoside is not absorbed but inhibits oil absorption in the small intestine of rodents.[Pubmed:18391464]
Biosci Biotechnol Biochem. 2008 Apr;72(4):1126-9.
Chiisanoside is the main component of Acanthopanax sessiliflorus leaves. Simultaneous administration of Chiisanoside resulted in a decrease in the plasma TG level and increase of undigested TG in the intestinal lumen after oil gavage to mice. This suggests that Chiisanoside has the potential to prevent obesity as a lipase inhibitor which suppresses fat absorption in vivo.
